期刊文献+

拉诺康唑的合成工艺研究

Study on the Synthetic Route of Lanoconazole
原文传递
导出
摘要 目的研究咪唑类抗真菌药物拉诺康唑的合成工艺。方法以邻氯扁桃酸为原料,经酯化、卤代、还原和甲磺酰酯化反应得到化合物4D,4D与1-咪唑基乙腈、二硫化碳、氢氧化钾反应得到二钾盐化合物3,然后经环合、构型转化,并分离纯化和重结晶制得拉诺康唑。结果总收率为36.5%(以邻氯扁桃酸计),各步关键中间体及目标物结构经MS和1H-NMR确证。结论该合成工艺操作简便,原料廉价易得,三废较少,适合工业化生产。 OBJECTIVE To study the the synthetic process of imidazole antifungal drug lanoconazole.METHODS Lanoconazole was synthesized using 2-Chloromandelic acid as the starting material,via esterification,halogenation,reduction,methylsulfonyl esterification to get compound 4D,followed by reaction with 1-imidazolyl acetonitrile,carbon disulfide and potassium hydroxide to get dipotassium salt compound 3,cyclization,configuration conversion,separation and recrystallization to get lanoconazole.RESULTS The total yield was 36.5%based on 2-Chloromandelic acid.The structures of lanoconazole and key intermediates in the process were confirmed by MS and 1H-NMR.CONCLUSION The synthetic process is simple in operation and suitable for industrial production with cheap and readily available raw materials and less waste.
作者 刚丽霞 张道明 张荣震 李达 盛荣 GANG Lixia;ZHANG Daoming;ZHANG Rongzhen;LI Da;SHENG Rong(College of Pharmaceutical Sciences of Zhejiang University,Hangzhou 310058,China;Zhejiang East-Asia Pharmaceutical Co.,Ltd.,Taizhou 317100,China;Shanghai RightHand PharmTech Co.,Ltd.,Shanghai 201318,China)
出处 《中国现代应用药学》 CAS CSCD 北大核心 2024年第15期2066-2070,共5页 Chinese Journal of Modern Applied Pharmacy
关键词 拉诺康唑 咪唑类抗真菌药物 合成工艺 lanoconazole imidazole antifungal drug synthetic route
  • 相关文献

参考文献3

二级参考文献30

  • 1李储君,盛建伟,任怡,郭春.抗真菌药兰诺康唑的合成[J].中国药物化学杂志,2006,16(2):88-90. 被引量:6
  • 2周林芳.氯吡格雷的合成路线研究[J].安徽医药,2006,10(8):614-616. 被引量:11
  • 3Seo A, Hiraga K, Omi T. Preparation of optically active ketene dithioketal derivative and its use as medicinal fungicide[P]. JP: 02 275 877, 1990-11-09.
  • 4Seo A, Kanno H, Hasegawa N, et al. Derivative, a process for manufacturing thereof and a method for curing mycosis by administering it[P]. US: 4 636 519, 1985-10-10.
  • 5Kobayashi Y, Mori H, Morita H. Process for producing 2- aryl-or 2-arylalkyl-1,2-ethanediol derivatives by reduction of α-hydroxy acid esters[P]. WO: 199 628 405, 1996-09-19.
  • 6Okada M, Kodaira T, Yabutani K. Preparation of (E)- imidazole derivative as agrochemical bactericide and fungicide [P]. JP: 02 121 983, 1990-05-09.
  • 7Donders G,Ausma J,Wouters L,et al.Efficacy of a single oral dose of 200 mg pramiconazole in vulvovaginal yeast infections:an exploratory phase Ⅱa trial.Acta Derm Venereol,2008,88(5):462-466.
  • 8Decroix J,Ausma J,Cauwenbergh G,et al.The efficacy of oral treatment with pramiconazole in tinea pedis and tinea cruris/cor poris:two exploratory phase Ⅱa trials.Br J Dermatol,2008,158 (4):854-856.
  • 9Aperis G,Mylonakis E.Newer triazole antifungal agents:pharmacology,spectrum,clinical efficacy and limitations.Expert Opin Investig Drugs,2006,15(6):579-602.
  • 10Pfaller MA,Messer SA,Hollis RJ,et al.In vitro activities of ravueonazole and voriconazole compared with those of four approved systemic antifungal agents against 6,970 clinical isolates of Candida spp.Antimicrob Agents Chemother,2002,46 (6):1723-1727.

共引文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部